Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs XBiotech Inc. (XBIT)

Champions Oncology, Inc. and XBiotech Inc. are both Biotechnology companies. Champions Oncology, Inc. and XBiotech Inc. are of similar size ($66.7M and $65.9M). Champions Oncology, Inc. grew revenue faster over the last twelve months: 6.65% against −78.2%. XBiotech Inc. has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (−159.2% vs −626.2%). Across the 17 metrics below, XBiotech Inc. leads on 9 and Champions Oncology, Inc. on 8.

Valuation

Metric CSBR XBIT Biotechnology median
P/E n/m n/m 8.50
P/S 1.08 16.12 9.71
P/B 14.65 0.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 196.33 0.74 0.64
EV/Sales 1.01 (8.64) 9.21
Earnings yield (1.70%) (69.81%) (33.15%)
Free cash flow yield (9.36%) (63.41%) (25.50%)

Profitability

Metric CSBR XBIT Biotechnology median
Gross margin 49.82% 0.00% 65.16%
Operating margin (1.68%) 0.00% 0.00%
Net margin (1.87%) 0.00% 0.00%
Free cash flow margin (10.08%) 0.00% 0.00%
Return on equity (28.38%) (29.94%) (56.36%)
Return on assets (3.56%) (28.90%) (48.04%)
Return on invested capital (626.23%) (159.18%) 0.00%

Growth

Metric CSBR XBIT Biotechnology median
Revenue growth (TTM) 6.65% (78.20%) 6.02%
EPS growth (last fiscal year) (124.24%) (18.25%) 30.26%
Revenue growth, 5-year CAGR 7.68% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR XBIT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.03 33.15 4.72
Net debt to EBITDA (20.56) 2.33 0.96

Dividend

Metric CSBR XBIT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CSBR XBIT Biotechnology median
Market cap 66.67m 65.85m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack